866-997-4948(US-Canada Toll Free)

United States Pneumonia Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

Notes:
Sales, means the sales volume of Pneumonia Vaccine
Revenue, means the sales value of Pneumonia Vaccine

This report studies sales (consumption) of Pneumonia Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
GlaxoSmithKline
Pfizer
Merck
...

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Split by applications, this report focuses on sales, market share and growth rate of Pneumonia Vaccine in each application, can be divided into
Pneumonia
Meningitis
Sepsis

Table of Contents

United States Pneumonia Vaccine Market Report 2017
1 Pneumonia Vaccine Overview
1.1 Product Overview and Scope of Pneumonia Vaccine
1.2 Classification of Pneumonia Vaccine
1.2.1 Pneumococcal Conjugate Vaccine (PCV13)
1.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.3 Application of Pneumonia Vaccine
1.3.1 Pneumonia
1.3.2 Meningitis
1.3.3 Sepsis
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Pneumonia Vaccine (2011-2021)
1.4.1 United States Pneumonia Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States Pneumonia Vaccine Revenue and Growth Rate (2011-2021)

2 United States Pneumonia Vaccine Competition by Manufacturers
2.1 United States Pneumonia Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Pneumonia Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Pneumonia Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Pneumonia Vaccine Market Competitive Situation and Trends
2.4.1 Pneumonia Vaccine Market Concentration Rate
2.4.2 Pneumonia Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Pneumonia Vaccine Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Pneumonia Vaccine Sales and Market Share by States (2011-2016)
3.2 United States Pneumonia Vaccine Revenue and Market Share by States (2011-2016)
3.3 United States Pneumonia Vaccine Price by States (2011-2016)

4 United States Pneumonia Vaccine Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Pneumonia Vaccine Sales and Market Share by Type (2011-2016)
4.2 United States Pneumonia Vaccine Revenue and Market Share by Type (2011-2016)
4.3 United States Pneumonia Vaccine Price by Type (2011-2016)
4.4 United States Pneumonia Vaccine Sales Growth Rate by Type (2011-2016)

5 United States Pneumonia Vaccine Sales (Volume) by Application (2011-2016)
5.1 United States Pneumonia Vaccine Sales and Market Share by Application (2011-2016)
5.2 United States Pneumonia Vaccine Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 United States Pneumonia Vaccine Manufacturers Profiles/Analysis
6.1 GlaxoSmithKline
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Pneumonia Vaccine Product Type, Application and Specification
6.1.2.1 Pneumococcal Conjugate Vaccine (PCV13)
6.1.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
6.1.3 GlaxoSmithKline Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Pneumonia Vaccine Product Type, Application and Specification
6.2.2.1 Pneumococcal Conjugate Vaccine (PCV13)
6.2.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
6.2.3 Pfizer Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.2 Pneumonia Vaccine Product Type, Application and Specification
6.3.2.1 Pneumococcal Conjugate Vaccine (PCV13)
6.3.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
6.3.3 Merck Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
...

7 Pneumonia Vaccine Manufacturing Cost Analysis
7.1 Pneumonia Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pneumonia Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Pneumonia Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pneumonia Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Pneumonia Vaccine Market Forecast (2016-2021)
11.1 United States Pneumonia Vaccine Sales, Revenue Forecast (2016-2021)
11.2 United States Pneumonia Vaccine Sales Forecast by Type (2016-2021)
11.3 United States Pneumonia Vaccine Sales Forecast by Application (2016-2021)
11.4 Pneumonia Vaccine Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Pneumonia Vaccine
Table Classification of Pneumonia Vaccine
Figure United States Sales Market Share of Pneumonia Vaccine by Type in 2015
Figure Pneumococcal Conjugate Vaccine (PCV13) Picture
Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Picture
Table Application of Pneumonia Vaccine
Figure United States Sales Market Share of Pneumonia Vaccine by Application in 2015
Figure Pneumonia Examples
Figure Meningitis Examples
Figure Sepsis Examples
Figure United States Pneumonia Vaccine Sales and Growth Rate (2011-2021)
Figure United States Pneumonia Vaccine Revenue and Growth Rate (2011-2021)
Table United States Pneumonia Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Pneumonia Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pneumonia Vaccine Sales Share by Manufacturers
Figure 2016 Pneumonia Vaccine Sales Share by Manufacturers
Table United States Pneumonia Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Pneumonia Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Pneumonia Vaccine Revenue Share by Manufacturers
Table 2016 United States Pneumonia Vaccine Revenue Share by Manufacturers
Table United States Market Pneumonia Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Pneumonia Vaccine Average Price of Key Manufacturers in 2015
Figure Pneumonia Vaccine Market Share of Top 3 Manufacturers
Figure Pneumonia Vaccine Market Share of Top 5 Manufacturers
Table United States Pneumonia Vaccine Sales by States (2011-2016)
Table United States Pneumonia Vaccine Sales Share by States (2011-2016)
Figure United States Pneumonia Vaccine Sales Market Share by States in 2015
Table United States Pneumonia Vaccine Revenue and Market Share by States (2011-2016)
Table United States Pneumonia Vaccine Revenue Share by States (2011-2016)
Figure Revenue Market Share of Pneumonia Vaccine by States (2011-2016)
Table United States Pneumonia Vaccine Price by States (2011-2016)
Table United States Pneumonia Vaccine Sales by Type (2011-2016)
Table United States Pneumonia Vaccine Sales Share by Type (2011-2016)
Figure United States Pneumonia Vaccine Sales Market Share by Type in 2015
Table United States Pneumonia Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Pneumonia Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pneumonia Vaccine by Type (2011-2016)
Table United States Pneumonia Vaccine Price by Type (2011-2016)
Figure United States Pneumonia Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Pneumonia Vaccine Sales by Application (2011-2016)
Table United States Pneumonia Vaccine Sales Market Share by Application (2011-2016)
Figure United States Pneumonia Vaccine Sales Market Share by Application in 2015
Table United States Pneumonia Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Pneumonia Vaccine Sales Growth Rate by Application (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Pneumonia Vaccine Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Pneumonia Vaccine Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Pneumonia Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Pneumonia Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pneumonia Vaccine
Figure Manufacturing Process Analysis of Pneumonia Vaccine
Figure Pneumonia Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pneumonia Vaccine Major Manufacturers in 2015
Table Major Buyers of Pneumonia Vaccine
Table Distributors/Traders List
Figure United States Pneumonia Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Pneumonia Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Pneumonia Vaccine Production Forecast by Type (2016-2021)
Table United States Pneumonia Vaccine Consumption Forecast by Application (2016-2021)
Table United States Pneumonia Vaccine Sales Forecast by States (2016-2021)
Table United States Pneumonia Vaccine Sales Share Forecast by States (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *